Non-viral, cell-targeting nucleic acid delivery platform
Targeted delivery for gene therapy
Pre-clinicalInternal R&D
Key Facts
About 4basebio
4basebio is an innovation-driven biotech focused on accelerating advanced therapy medicinal products (ATMPs) through its high-performance synthetic DNA products and non-viral delivery platform. The company's core technology, TruePrime®, is a primer-free, enzymatic DNA amplification process that eliminates bacterial sequences and antibiotic resistance genes, offering a cleaner, faster, and more scalable alternative to plasmid DNA. With a recent CEO transition and a key supply agreement leading to a partner's clinical trial, 4basebio is positioning itself as a critical enabler for next-generation genetic medicines, from research through GMP-grade commercial production.
View full company profile